4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-20-033783
Director sold 33,000 shares at an average $143.35 ($4,730,448)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bolzon Bradley J PhD Director | 2020-12-10 | Sale | −2,271 | $140.62 | $319,345 | 344,915 | I |
| Bolzon Bradley J PhD Director | 2020-12-10 | Sale | −6,648 | $141.53 | $940,923 | 338,267 | I |
| Bolzon Bradley J PhD Director | 2020-12-10 | Sale | −5,958 | $142.42 | $848,562 | 332,309 | I |
| Bolzon Bradley J PhD Director | 2020-12-10 | Sale | −2,223 | $143.26 | $318,462 | 330,086 | I |
| Bolzon Bradley J PhD Director | 2020-12-10 | Sale | −15,900 | $144.85 | $2,303,155 | 314,186 | I |
| Open-market sales · 33,000 sh · avg $143.35 · $4,730,448 | |||||||
Loading xslF345X03/doc4.xml…